adèle green, mbbs, ph.d. · adèle green, mbbs, ph.d. australia . address: qimr berghofer medical...

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2018\BiosketchSC2018_Revised2.docx of 25

AUSTRALIA (elected in 2016 – mandate expires in 2020) Adèle GREEN, MBBS, Ph.D.

AUSTRALIA ADDRESS: QIMR Berghofer Medical Research Institute Royal Brisbane Hospital, QLD 4029 Australia E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1976 1984 1985 1990 2014

University of Queensland University of Queensland London School of Hygiene & Tropical Medicine Australasian Faculty of Public Health Medicine Australian Academy of Health and Medical Science

MB, BS (Honours I) PhD Epidemiology MSc Epidemiology Fellow Fellow

PRINCIPAL POSITIONS HELD YEAR POSITION AND PLACE OF EMPLOYMENT

1977 1978 1979

1980–1985

1986 1987–1992 1992–1996

1995

1996–1999 1996–2011

1997 2005–2009

2010 2000–2011

2000–

2002–

2009– 2012– 2014–

Previous appointments: Resident Medical Officer, Mater Misericordiae Hospital, Brisbane Resident Medical Officer, Cairns Base Hospital, Cairns Medical Registrar, Mater Misericordiae Hospital, Brisbane NHMRC Research Scholar and Fellow, QIMR; University of London; Oxford

University Visiting Lecturer in Medicine, Harvard Medical School, Boston, USA Senior Research Fellow, QIMR & Tropical Health Program Principal Research Fellow, QIMR & Conjoint Associate Professor, Australian

Centre for International Tropical Health and Nutrition, University of Queensland

Honorary Consultant in Medical Research, Mater Misericordiae Hospital, Brisbane

Head, Epidemiology and Population Health Unit, QIMR Senior Principal Research Fellow, QIMR Visiting Medical Research Officer, The Wellcome Trust, London Adjunct Professor, Griffith University Acting Director, QIMR Deputy Director, QIMR Present appointments: Head, Cancer and Population Studies Group, QIMR Berghofer Medical Research

Institute (formerly Queensland Institute of Medical Research (QIMR)) Professor, University of Queensland Conjoint Professor, Queensland University of Technology Professor, Institute of Inflammation and Repair, University of Manchester Senior Scientist, QIMR Berghofer Medical Research Institute Senior Research Scientist, Cancer Research UK Manchester Institute, University

of Manchester

RESEARCH INTERESTS Cancer etiology, prevention and implementation research, health services and policy.

mailto:[email protected]


AUSTRIA (elected in 2017 – mandate expires in 2021)

Maria SIBILIA, Ph.D. AUSTRIA

ADDRESS: Institute of Cancer Research Medical University of Vienna Comprehensive Cancer Center Vienna E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1990–1992

University of Pavia and Department of Biotechnology and Virology, Brescia, Italy

Ph.D. Genetics and Molecular Biology


1993–1996

1996–1998 1999–2002

2002–2007

April 2007

2010–present

Postdoctoral fellow at the Institute of Molecular Pathology (IMP), Vienna, Austria

Staff Scientist at the Institute of Molecular Pathology (IMP), Vienna, Austria Assistant Professor at the Department of Dermatology, DIAID,

University of Vienna Medical School, Vienna, Austria Associate Professor at the Department of Dermatology, DIAID,

University of Vienna Medical School, Vienna, Austria Full Professor for Cellular and Molecular Tumorbiology, Head of the

Research Unit Cellular and Molecular Tumorbiology Institute for Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria

Head of the Institute of Cancer Research, Medical University Vienna

RESEARCH INTERESTS Molecular medicine; tumour immunology; inflammation.



BELGIUM (elected in 2016 – mandate expires in 2020) Roberto SALGADO, M.D., Ph.D.

BELGIUM ADDRESS: Department of Pathology, GZA Hospital, Antwerp & Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1998 2004

University of Antwerp, Belgium University of Antwerp, Belgium

M.D. Ph.D.


2006–2010

2006–

2010–

Pathology Resident and Lead of the Molecular Pathology Unit and Quality Assurance Unit, Jules Bordet Institute, Brussels

Member, Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels and the Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia

Member, EORTC, co-lead of the Pathobiology Group and SPECTA-lead Pathology Resident, GZA Hospitals, Antwerp

RESEARCH INTERESTS Molecular pathology, solid tumours, in particular breast cancer, circulating tumour biomarkers, next generation sequencing technologies, validation of biomarkers, innovative clinical trials incorporating genomics, quality assurance of genomic technologies, development of biomarkers in immunotherapeutic trials, with a focus on Tumor Infiltrating Lymphocytes (TILs).



BRAZIL (elected in 2017 – mandate expires in 2021)

João P.B. VIOLA, M.D., M.Sc., Ph.D. BRAZIL

ADDRESS: Head, Division of Experimental and Translational Research National Cancer Institute (INCA) Rio de Janeiro E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1989

1994

1998

School of Medicine, State University of Rio de Janeiro (UERJ), Brazil

Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Brazil

Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro (UFRJ), Brazil

M.D. M.Sc. Parasite Biology Ph.D. Biophysics


1994

1994–1997

1998–2006 2006–2009

2009–present 2012–present

2016–present

Visiting Fellow in Tropical Public Health, Department of Tropical Public Health, Harvard School of Public Health, USA.

Research Associate in Pathology, Dana-Farber Cancer Institute and The Center for Blood Research, Department of Pathology, Harvard Medical School, USA.

Investigator, National Cancer Institute (INCA), Brazil. Associate Investigator, National Cancer Institute (INCA), Brazil. Senior Investigator, National Cancer Institute (INCA), Brazil. Head, Division of Experimental and Translational Research, National Cancer

Institute (INCA), Brazil. Head, Program of Tumor Immunology and Immunotherapy, National Cancer

Institute (INCA), Brazil.

RESEARCH INTERESTS Tumour immunology; cancer cell transformation.



CANADA (elected in 2017 – mandate expires in 2021) Christine FRIEDENREICH, B.Sc., M.Sc., Ph.D.

CANADA ADDRESS: Scientific Leader, Department of Cancer Epidemiology and Prevention Research Alberta Health Services Head, Division of Preventive Oncology University of Calgary’s Department of Oncology, Calgary, Alberta E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION 1980 – 1982

1984 – 1986

1986 – 1990

Queen's University, Kingston Department of Community Health and

Epidemiology, Queen's University, Kingston Department of Preventive Medicine and

Biostatistics, University of Toronto

B.Sc. (Honours), Life Sciences M.Sc. in Epidemiology Ph.D. in Epidemiology

PRINCIPAL POSITIONS HELD YEAR POSITION AND PLACE OF EMPLOYMENT 1990 – 1991 1992 – 1994

1995 – 1997

1995 – 2000

1997 – 2003

2000 – 2006

2003 – 2011

2006 – present

2007 – present

2011 – 2013

2009 – 2011

2012 – 2017

2013 – present

Postdoctoral Research Training Fellow, IARC, Lyon, France Postdoctoral Fellow, Community Health Sciences Department, University of

Calgary (UofC) Research Scientist II, Division of Epidemiology, Prevention & Screening, Alberta

Cancer Board Adjunct Assistant Professor, Department of Community Health Sciences,

UofC Research Scientist III, Division of Epidemiology, Prevention and Screening,

Alberta Cancer Board Adjunct Associate Professor, Department of Community Health Sciences,

UofC Adjunct Associate Professor, Faculty of Kinesiology, UofC Scientific Leader, Population Health Research, Division of Population Health

and Information, Alberta Cancer Board Adjunct Professor, Community Health Sciences, Cumming School of Medicine,

UofC Adjunct Professor, Faculty of Kinesiology, UofC Adjunct Professor, Oncology and Community Health Sciences,

Cumming School of Medicine, UofC Senior Research Scientist, Population Health Research, Alberta Cancer

Board Acting Division Head, Division of Preventive Oncology, Department of

Oncology, Faculty of Medicine, UofC Alberta Cancer Foundation Weekend to End Women’s Cancers Breast Cancer

Chair, Cumming School of Medicine, UofC Scientific Leader, Cancer Epidemiology and Prevention Research, Alberta

Health Services Division Head, Division of Preventive Oncology, Department of Oncology,

Cumming School of Medicine, UofC RESEARCH INTERESTS Cancer etiology, prevention and survival; physical activity; diet; obesity; biologic mechanisms; intervention trials.



DENMARK (elected in 2014 – mandate expires in 2018) Ole Raaschou-Nielsen, M.Sc., Ph.D.

DENMARK ADDRESS: Danish Cancer Society, Department of Work, Environment and Cancer DK 2100 Copenhagen Ø E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1990 1998

University of Roskilde, DK University of Copenhagen, DK

M.Sc. – Environmental Science Ph.D. – Epidemiology


1990–1993 1993–2001 2001–2011

2011– 2014–

Industrial hygienist, Occupational Health Service, Municipality of Copenhagen Research Fellow, Institute of Cancer Epidemiology, Danish Cancer Society Group Leader, Environment and Cancer, Danish Cancer Society Group Leader, Work, Environment and Cancer, Danish Cancer Society Professor at Department of Environmental Science, Aarhus University

RESEARCH INTERESTS Epidemiology; cancer, environment; exposure assessment; air pollution and health; biomarkers in cancer epidemiology.



FINLAND (elected in 2014 – mandate expires in 2018) Elisabete WEIDERPASS VAINIO, M.D., M.Sc., Ph.D.

FINLAND ADDRESS: Program on Genetic Research, Genetic Epidemiology Group Folkhälsan Research Center, Biomedicum 1 Haartmansgatan 8, PB 63 (B336b), FI-00014 University of Helsinki, Helsinki, Finland E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1986–1992 1993–1994 1995–1999

Federal University of Pelotas, RS, Brazil Federal University of Pelotas, RS, Brazil Karolinska Institutet, Stockholm, Sweden

M.D. M.Sc. – Epidemiology Ph.D. – Cancer Epidemiology

PRINCIPAL POSITIONS HELD YEAR POSITION AND PLACE OF EMPLOYMENT 1999–2000 Scientist, Department of Medical Epidemiology and Biostatistics, Karolinska

Institutet, Stockholm, Sweden (MEB-KI) 2000–2005 Assistant Professor in Cancer Epidemiology (Docent), (MEB-KI). 2001–2004 Medical Officer, Unit of Field and Intervention Studies, International Agency

for Research on Cancer (IARC), Lyon, France 2003–2004 Associate Professor in Cancer Epidemiology (Docent; in 2004 nominated to

Professor in Cancer Epidemiology), School of Public Health, Tampere University

2004 Senior Cancer Epidemiologist, Finnish Cancer Registry, Helsinki, Finland 2004–2014 Senior Cancer Epidemiologist, Department of Research, Cancer Registry of

Norway, Oslo, Norway 2005–2011 Associate Professor in Medical Epidemiology, (MEB-KI) 2007–present Leader, Genetic Epidemiology Group, Program for Genetic Research,

Folkhälsan Research Center, Helsinki, Finland 2008–present Professor of Cancer Epidemiology, Department of Community Medicine,

Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway

2011–present Professor of Medical Epidemiology, (MEB-KI) 2013–2016 Visiting Adjunct Professor of Cancer Epidemiology, Gansu Provincial

Maternity and Child Care Hospital, Lanzhou, P.R.China 2015–present Head of Research Department; Head of Etiological Cancer Research Group;

Oslo University Hospital, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway

2016–present Visiting Professor, Dasman Diabetes Institute, Kuwait City, Kuwait 2017–present Visiting Professor, Donggang Branch, First Hospital of Lanzhou University,

P.R. China 2017–present Visiting Professor, Faculty of Medicine, University of Helsinki, Helsinki,

Finland RESEARCH INTERESTS Cancer epidemiology; etiological risk factors; cancer screening; cancer survival; pharmacoepidemiology; infectious diseases and cancer; cancer research in developing countries; cancer registration.



FRANCE (elected in 2017 – mandate expires in 2021)

Jacqueline CLAVEL, M.D., Ph.D. FRANCE

ADDRESS: Director of Research INSERM U1153 / EQUIPE 7 / EPICEA Paris E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1981 1988 1995

Paris Descartes University, Necker Faculty Paris-Sud University Paris-Sud University

Doctor in Medicine Master of Biostatistics and Health PhD in Epidemiology


1984–1988 1991–present 1994–present

1999–present 2006–2009

2010–2014

2011–present

2015–present

Assistant in physiology, Paris hospital and university Permanent position at Inserm (1991-CR2, 1995-CR1, 2000-DR2, 2009-DR1) Creation and direction of the National registry of childhood hematopoietic

malignancies (retroactive 1990-…) Co-creation of the National registry of childhood solid tumours Director of the research unit « Environmental epidemiology of cancers »,

INSERM UMR-S754 Leader of the Inserm team « Environmental epidemiology of cancers » of the

Research center of epidemiology and population health (CESP), INSERM U1018 (Dir. D. Hémon)

Direction of the infrastructure (Investment for the future) HOPE-EPI and of the Platform of the National registry of childhood cancer (registration of treatments and response to treatments, national virtual biobank, national systematic follow-up, national GIS-based assessment of environmental exposures)

Leader of the Inserm team « Epidemiology of cancers of children and adolescents » (EPICEA) of the Research center of epidemiology and statistics of Paris-Sorbonne-Cité (CRESS), INSERM U1153 (Dir. P. Ravaud)

RESEARCH INTERESTS Environmental epidemiology; childhood cancer; cancer registries.



GERMANY (elected in 2015 – mandate expires in 2019) Jenny CHANG-CLAUDE, Ph.D., MHS

GERMANY ADDRESS: Head, Unit of Genetic Epidemiology Deputy Head, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1971–1975 1975–1977

1990

1997

Wilson College Johns Hopkins University, School of Hygiene

and Public Health, Baltimore, USA Ruprecht-Karls-University Heidelberg,

Faculty of Theoretical Medicine Ruprecht-Karls-University of Heidelberg

B.A., Major in Biochemistry Master of Health Science

(M.H.S.) in Epidemiology and Human Genetics

Dissertation Dr. sc. hum., (summa cum laude)

Habilitation in Epidemiology


1977–1994

1994– 1997 1999– 2004–

2015 (part-time)–

Research Scientist, Division of Epidemiology, DKFZ Head, Unit of “Genetic Epidemiology”, Division of Cancer Epidemiology, DKFZ Venia Legendi, Medical Faculty, University of Heidelberg Deputy Head, Division of Cancer Epidemiology, DKFZ Professor of Epidemiology at the Medical Faculty, University of Heidelberg Head, “Genetic Tumorepidemiology” Research Group, University Cancer Center

Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

RESEARCH INTERESTS Genetic epidemiology; breast, ovarian and colorectal cancers.



INDIA (elected in 2015 – mandate expires in 2019) Lalit KUMAR, M.D., D.M.

INDIA ADDRESS: Professor & Head of Medical Oncology Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi 11 00 29 E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1984 1988

SN Medical College (Agra University, Agra) Madras (Madras University, Chennai)

M.D. Medicine D.M. Medical Oncology


1983–1984 1984–1986 1988–1989 1989–1996

1992 1996–2000 2000–2005 2005–date 2013–date

Resident Medical Officer, Department of Medicine, SN Medical College, Agra Senior Resident in Medical Oncology, IRCH AIIMS, New Delhi Pool Officer (CSIR) in Medical Oncology, IRCH AIIMS, New Delhi Assistant Professor of Medical Oncology, IRCH AIIMS, New Delhi Honorary Senior Registrar in Haematology, Hammersmith Hospital, London Associate Professor of Medical Oncology, IRCH AIIMS, New Delhi Additional Professor of Medical Oncology, IRCH AIIMS, New Delhi Professor of Medical Oncology, IRCH-AIIMS, New Delhi Professor and Head, Medical Oncology, IRCH-AIIMS

RESEARCH INTERESTS Clinical oncology; bone marrow/stem cell transplantation; multiple myeloma; gynecological malignancies.



IRELAND (elected in 2015 – mandate expires in 2019)

Jerome COFFEY, MD FRCPI FRCR FFRRCSI IRELAND

ADDRESS: Director, The National Cancer Control Programme Dublin D01 A3Y8 E-mail: [email protected]

EDUCATION YEAR INSTITUTION QUALIFICATION

1993 1998 2001 2001

2010 2012

Trinity College Dublin, Ireland Royal College of Physicians in Ireland Royal College of Radiologists, UK Faculty of Radiologists (Royal College of Surgeons in

Ireland) University of London Royal College of Physicians in Ireland

MB BAO BA BCh MRCPI FRCR FFRRCSI MD FRCPI


1993–1994 1994–1996 1996–2001 2001–2003 2003–2006

2006–

2010–2014

2012–2014 2012–2014

2014–2015

2015– 2014–

Internship: Adelaide & Meath Hospitals, Dublin, Ireland Senior House Officer: Limerick, Meath & St James's Hospitals, Ireland Radiation Oncology Residency Training Programme: St Luke's Hospital, Ireland Radiation Oncology Fellowship: Princess Margaret Hospital, Toronto, Ca Clinical Research Fellowships: Royal Marsden Hospital & Institute for Cancer

Research, UK Consultant Radiation Oncologist: St Luke's Radiation Oncology Network, Dublin,

Ireland National Clinical Lead for Radiation Oncology: National Cancer Control

Programme, Ireland Clinical Director, St Luke's Radiation Oncology Network, Dublin, Ireland Chair Radiation Oncology Committee and Faculty Board Member: Faculty of

Radiologists, RCSI, Dublin, Ireland Interim Director National Cancer Control Programme, Dublin, Ireland Director National Cancer Control Programme, Dublin, Ireland Member Health Service Executive Leadership Team, Dublin, Ireland

RESEARCH INTERESTS The management of breast and urological cancers, especially testicular germ cell tumours and prostate.



ITALY (elected in 2015 – mandate expires in 2019) Eugenia DOGLIOTTI, Ph.D.

ITALY ADDRESS: Head, Department of Environment and Health Istituto Superiore di Sanità, 00161 Rome E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1976

La Sapienza University, Rome

Ph.D. Biological Sciences


1981–1992

1984-1987

1993–1999

2000–2016

2017–

Research Scientist, Laboratory of Toxicology, Istituto Superiore di Sanità,

Rome Visiting Scientist, Department of Chemistry and Whitaker College of Health

Sciences and Technology, Massachusetts Institute of Technology, Cambridge (MA), USA

Senior Scientist, Laboratory of Applied Toxicology, Istituto Superiore di Sanità

Director of Research, Head of the Unit of Molecular Epidemiology, Department of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome

Head of the Department of Environment and Health, Istituto Superiore di Sanità, Rome

RESEARCH INTERESTS Mechanisms of DNA repair and mutagenesis; molecular cancer epidemiology.



JAPAN (elected in 2016 – mandate expires in 2020) Atsushi OCHIAI, M.D., Ph.D.

JAPAN ADDRESS: Exploratory Oncology Research and Clinical Trial Center National Cancer Center, Tokyo E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1976–1982 1982–1986

Hiroshima University Hiroshima University

M.D. Ph.D.


1987–1988 1988–1991

1991–1994

1988–2016

2002–

2010–2016

2012–

2013–2016

2014– 2014– 2014– 2016–

Assistant Professor, Hiroshima University Senior Researcher, Alexander von Humboldt Foundation, Hannover

University, West Germany Staff Scientist and Section Head, Pathology Division, National Cancer Center

Research Institute Chief, Pathology Division, Research Center for Innovative Oncology, National

Cancer Center Hospital East Professor, Laboratory of Cancer Biology, Graduate School of Frontier

Sciences, University of Tokyo Chief, Department of Pathology and Clinical Laboratory, National Cancer

Center Hospital East Group leader, Group for Innovative Integrated Diagnosis and NCC-Biobank,

Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba

Chief, Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tsukiji Tokyo

Deputy Director, National Cancer Center Research Institute Professor, Graduate School of Medical Sciences, Keio University Professor, Graduate School of Medicine, Hiroshima University Director, Exploratory Oncology Research and Clinical Trial Center, National

Cancer Center, Tokyo

RESEARCH INTERESTS Mechanisms of cancer progression, tumour microenvironment, cancer therapeutics.



MOROCCO (elected in 2015 – mandate expires in 2019) Karima EL RHAZI, M.D., Ph.D.

MOROCCO ADDRESS: Department of Epidemiology and Public Health Faculty of Medicine of Fez, Morocco E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

2000 2003

2004

2004

2005

2005

2006 2006

2009

2010

Faculty of Medicine of Rabat, Morocco University Paris VI, Paris, France Institut de Santé Publique d’Epidémiologie

et de Développement, University Victor Segalen Bordeaux 2, France

University Paris VI, Paris, France University Paris VI, Paris, France Institut de Santé Publique d’Epidémiologie

et de Développement, University Victor Segalen Bordeaux 2, France

University of Bordeaux, France Faculty of Medicine of Fez, Morocco Imperial College London, UK University Victor Segalen, Bordeaux, France

Medical Diploma in Medicine University Diploma (UD): Statistics applied to research

University certificate (UC): Statistical modelization

UC Epidemiology: principles and quantitative methods

UC Statistics applied to medical biology

UD « Hygiène Hospitalière et prévention des infections associées aux soins »

M.Sc. Clinical Epidemiology Diploma of Specialty in Public Health and Epidemiology

Certificate of Nutritional Epidemiology

Ph.D. Epidemiology & Public Health


2006

2007 to date 2012 to date

2014–2017

Specialist in Public Health and Epidemiology, Health delegation of the Ministry

of Health, Meknes, Morocco Professor in Epidemiology and Community Medicine, Fez Faculty of Medicine Member of the Cancer Hospital Registry, HASSAN II University Hospital

Center of Fez Director, Research Laboratory “Epidemiology, Clinical Research and

Community Health”, Faculty of Medicine and Pharmacy of Fez

RESEARCH INTERESTS Cancer epidemiology and public health; cancer control; tobacco and respiratory epidemiology; nutritional epidemiology; quality of life.



THE NETHERLANDS (elected in 2014 – mandate expires in 2018) Ellen KAMPMAN, B.Sc., M.Sc., Ph.D.

THE NETHERLANDS ADDRESS: Professor in Nutrition and Disease

Wageningen University Division of Human Nutrition PO BOX 17 6700 AA Wageningen, The Netherlands

E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1985 1988 1994

Wageningen University, NL Wageningen University, NL University of Maastricht, NL

B.Sc. – Human Nutrition M.Sc. – Human Nutrition, with distinction Ph.D. – Cancer Epidemiology


1986

1988–1989 1989–1994 1991–1992

1994–1996

1996–1999 1999–2004 2000–2002

2004–2007

2005–

2008–2015 2010–2015

2015–

M.Sc. training period, Athens School of Public Health, Department of Nutrition,

Athens, Greece Cancer Register, Comprehensive Cancer Centre Netherlands, Utrecht, NL Ph.D. Student, TNO Food and Nutrition Institute, Zeist, NL Visiting Scholar, Harvard School of Public Health, Departments of Nutrition &

Epidemiology, Boston, USA Postdoctoral Fellow Dutch Cancer Society, Fred Hutchinson Cancer Research

Center, Department of Cancer Prevention, Seattle, USA Junior Epidemiologist, Wageningen University, Division of Human Nutrition, NL Assistant Professor, Nutritional Epidemiology, Wageningen University, NL Course Director (Nutrition and Health), Education Institute Technology and

Nutrition, Wageningen University, NL Associate Professor, Nutritional Epidemiology, Wageningen University, NL Senior Epidemiologist, Principal Investigator, Radboud University Medical

Centre, Nijmegen, NL Personal Professor in Diet and Cancer, Wageningen University, NL Professor in Diet and Cancer, Free University Amsterdam, NL Full professor and Chair Nutrition and Disease, Wageningen University, NL

RESEARCH INTERESTS Nutrition, Epidemiology, Multifactorial causes of cancer, including diet and genetic susceptibility.



NORWAY (elected in 2015 – mandate expires in 2019) Giske URSIN, M.D., MPH, Ph.D.

NORWAY ADDRESS: Cancer Registry of Norway 0304 Oslo E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1985 1987 1992

University of California, Los Angeles, CA, USA University of Bergen, Norway University of California, Los Angeles, CA, USA

MPH, Epidemiology M.D. Ph.D., Epidemiology


1984–1986

7/1987–1/1989 6-9/1990 & 9/91

1992–1995

1995–1997

1997–1998

1998–2001

2001–2009

2001–2014

2009–2010

2010–present


Research Fellow, Dept. of Epidemiology & Preventive Medicine, Univ. of Bergen, Norway

Internship, Norway. Licensed MD, Norway, 1989 Visiting Scientist at National Cancer Institute, Bethesda, Maryland, USA Postdoctoral Fellow, Dept. of Preventive Medicine, University of Southern

California (USC) School of Medicine, Los Angeles, CA, USA Research Assistant Professor, Dept. of Preventive Medicine, USC Keck

School of Medicine, USA Assistant Professor of Research, Dept. of Preventive Medicine, USC Keck

School of Medicine, USA Assistant Professor, Dept. of Preventive Medicine, USC Keck School of

Medicine, USA Associate Professor with tenure, Dept. of Preventive Med., USC School of

Medicine, USA Professor, Dept. of Nutrition, Institute of Basic Medical Sciences, University

of Oslo, Norway Professor with tenure, Dept. of Preventive Medicine, USC Keck School of

Medicine, USA Professor Emeritae of Preventive Medicine, Dept. of Preventive Med., USC

School of Medicine, USA Director, Cancer Registry of Norway Professor II, Dept. of Nutrition, Institute of Basic Medical Sciences,

University of Oslo, Norway

RESEARCH INTERESTS Cancer registration; cancer epidemiology; nutritional epidemiology; gene-environment interactions.



QATAR (elected in 2017 – mandate expires in 2021) Salha M. BUJASSOUM Al BADER, M.B.B.S

STATE OF QATAR ADDRESS: National Center for Cancer Care & Research, Hamad Medical Corporation P.O. Box 3050, Doha, Qatar E-mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1991–1993 1996–1999

2000 1999–2002

2001 2002 2004

King Saud University HMC, Doha, Qatar University of Toronto, Toronto, Canada The Royal College of Physician & Surgeon of Canada The Royal College of Physician & Surgeon of Canada The Royal College of Physician & Surgeon of Canada The Royal College of Physician & Surgeon of Canada

M.B.B.S Internship & Residency American Board (Internal Medicine) Fellowship Hematology/Oncology Certification of Clinical Hematology American board of Clinical Hematology American board of Medical Oncology


1991–1992 1993–1995 1996–1997 1997–1998 1998–1999 1999–2000 2000–2001

2001

2001–2002

2002

2003–present

2010–present 2003–present 2003–2013

2004–present 2011–present 2013–present

Previous appointments: Internship – Hamad Medical Corporation, Doha Qatar Resident, General Internal Medicine – Hamad Medical Corporation PGY1, General Internal Medicine – Mount Sinai Hospital Toronto–ON PGY1, General Internal Medicine – St. Michael's Hospital Toronto–ON PGY3, General Internal Medicine – The Toronto Hospital Toronto–ON PGY4, Hematology & Oncology Program – Princess Margaret Hospital Toronto–ON PGY5, Hematology & Oncology Program – Princess Margaret Hospital Toronto–ON Clinical Observation, Bone Marrow Transplant – The University of Texas MD

Anderson, USA PGY6, Hematology & Oncology Program – Princess Margaret Hospital, Toronto,

Canada Fellowship in Bone Marrow Transplant, Princess Margaret Hospital, Toronto,

Canada Present appointments: Senior Consultant, Medical Oncology/Hematogy, NCCCR – Hamad Medical Corp.

Qatar Fellowship Program Director, Medical Oncology Medical Treatment Abroad Committee Member Chairperson, Infection Control Committee, NCCCR – Hamad Medical Corp. Qatar Member of Quality Management and Patient Safety Committee – NCCCR Clinical Lead Breast MDT, Co–Chair for Qatar Breast Tumor Board Director of HMC High Risk Screening Clinic, Lead of Cancer Genetic Program

RESEARCH INTERESTS Cancer prevention, screening, implementation research, medical oncology education, cancer genetic and gynecological malignancy biology and management.



REPUBLIC OF KOREA (elected in 2015 – mandate expires in 2019) Dukhyoung LEE, M.D., Ph.D.

REPUBLIC OF KOREA ADDRESS: Director, National Cancer Control Institute, National Cancer Center Korea 323, Ilsan–ro, Ilsandong–gu, Goyang–si, Gyeonggi–do, 10408 E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1975–1981

1984–1989

Seoul National University College of Medicine (SNUCM)

Seoul National University Graduate School

M.D. Ph.D. – Preventive Medicine


1981–1984 1984–1987 1987–1988 1988–1994

1988–1992 1992–1993

1994–1995 1995–1997 1997–2001

2001–2003 2003–2004 2004–2007

2008–2010 2010–2013

2013–2013 2013–date

Public Health Physician, Jeongseon–gun and Hongcheon–gun Teaching & Research Assistant, Preventive Medicine, SNUCM Chief of Epidemiology, AIDS Center, National Institute of Health (NIH) Medical Officer, National Sorok–do Hospital, Ministry of Health & Welfare (MOHW)

Seconded to Communicable Disease Control Division, MOHW Visiting Scholar, Leonard Davis Institute of Health Economics, University of Pennsylvania

Division Director of communicable disease control, MOHW Officer of Public Health Administration, Training Department, NIH Division Director of communicable disease control, health resources, disease control, cancer control, MOHW

Director, National Masan (Tuberculosis) Hospital, MOHW Director, Incheon Airport National Quarantine Station, MOHW Director, Epidemic Surveillance & Response Center, Korea Centers for Disease Control & Prevention (KCDC), MOHW

Director, Disease Policy, MOHW Director, Disease Prevention Center/Organ Sharing Management Center, KCDC, MOHW

Acting Director, KCDC, MOHW Director, National Cancer Control Institute, NCC

RESEARCH INTERESTS Cancer prevention and control; cancer surveillance.



RUSSIAN FEDERATION (elected in 2015 – mandate expires in 2019) Boris Ya. ALEKSEEV, M.D., Ph.D.

RUSSIAN FEDERATION ADDRESS: Deputy Director for Scientific Affairs Federal Medical Research Centre named after P.A. Gertsen, Moscow 125284 E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1992 1999

2002–2006

2007

2010

2012

Russian State Medical University, Moscow Moscow scientific and research oncology

institution named after P.A. Gertsen, Ministry of Healthcare, Moscow

Moscow Medical Academy named after I.M. Sechenov, Moscow

Higher certification committee, Russian Federation Ministry of Education and Science

Higher certification committee, Russian Federation Ministry of Education and Science

First Moscow State Medical University named after I.M. Sechenov, Moscow

M.D. – General medicine Ph.D. – Medicine Certificate of Oncologist Dr Med. Sci. Professor of Medicine Certificate of Urologist


1994–2002

2002–2010

2010–2011

2011–2013

2009–date

2013–date

Research Fellow, Moscow scientific and research oncology institution named after P.A. Gertsen, Russian Federation Ministry of Healthcare, Moscow

Senior Research Associate, Moscow scientific and research oncology institution named after P.A. Gertsen, Russian Federation Ministry of Healthcare, Moscow

Lead Research Associate, Moscow scientific and research oncology institution named after P.A. Gertsen, Russian Federation Ministry of Healthcare, Moscow

Head, Oncology and Urology Department, Moscow scientific and research oncology institution named after P.A. Gertsen, Russian Federation Ministry of Healthcare, Moscow

Head, Oncology and Urology Department, People’s Friendship University, Moscow

Deputy Director for Scientific Affairs, Federal State Budgetary Institution "Federal Medical Research Centre named after P.A.Gertsen", Ministry of Health of the Russian Federation

RESEARCH INTERESTS Clinical oncology; cancer biomarkers; urology.



SPAIN (elected in 2016 – mandate expires in 2020) Pilar SANCHEZ GOMEZ, Ph.D.

SPAIN ADDRESS: Neurooncology Unit, Chronic Disease Program lnstituto de Salud Carlos III, Madrid, Spain

E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1984 2000

Universidad Autónoma de Madrid Centro de Biologia Molecular, Madrid

B.S. (Biochemistry) Ph.D. (Biochemistry)


2000–2003

2003–2004 2004–2008

2008–

Assistant Researcher in Neurobiology, Skirball Institute, NYU School of

Medicine, New York, USA Assistant Researcher in Neurobiology, Geneva University, Switzerland Ramon y Cajal Researcher, Assistant Professor, Universidad de Valencia,

Spain Head of Neurooncology Unit, Chronic Disease Program, lnstituto de Salud

Carlos III, Madrid, Spain

RESEARCH INTERESTS Brain tumours, preclinical tests, cancer therapeutics, molecular pathology, tumour microenvironment.



SWEDEN (elected in 2015 – mandate expires in 2019) Jonas BERGH, M.D., Ph.D.

SWEDEN ADDRESS: Karolinska Institutet and University Hospital

Radiumhemmet S 171 76 Stockholm, Sweden E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1973–1979 1979–1984

University of Umeå and Uppsala, Sweden University of Uppsala, Sweden

Medical degree Doctoral degree


1982–1985 1985–1988 1986–2000 1988–1992 1992–1998

1999–

2000–2008 2007–2009 2009–2010

2008–

2009–2010

2010–2015 2011–

2011–2016

2012– 2012– 2016– 2016–

2017–2019 2017–

Resident, Surgical Pathology, Uppsala University, Sweden Resident, Medical and Radiation Oncology, Uppsala University Associate Professor in Experimental Oncology, Uppsala University Hospital Specialist in Oncology, Uppsala University Hospital Consultant in Oncology, Uppsala University Hospital Consultant in Oncology, Karolinska University Hospital, Radiumhemmet,

Stockholm Professor of Clinical and Molecular Oncology, Karolinska Institutet, Stockholm Scientific Director, Karolinska Oncology Professor of Breast Oncology & Director, Manchester Breast Cancer Centre Professor of Oncology, Karolinska Institutet & Consultant in Oncology,

Radiumhemmet, Karolinska University Hospital Professor of Breast Oncology (80% Edith Muriel Rickman Chair), Manchester

University, Director Manchester Breast Centre Director BRECT, Karolinska Institutet and County Council Chairman, Research and Education Committee, Karolinska Oncology and

Cancer Center Karolinska Vice–Chairman, EMA SAG Oncology–Haematology, London Co–Chair, EBCTCG, Oxford Fellow Royal College of Physicians, London Director, Strategic Research Program in Cancer, Karolinska Institutet Acting Chair, EMA SAG Oncology–Haematology, London Honorary Professor, Oxford University Member of the Nobel Assembly, Karolinska Institutet

RESEARCH INTERESTS Clinical oncology; cancer biomarkers; breast cancer.



SWITZERLAND (elected in 2014 – mandate expires in 2018) Martin RÖÖSLI, M.Sc., Ph.D.

SWITZERLAND ADDRESS: Head of the Environmental Exposures and Health Unit Swiss Tropical and Public Health Institute, 4002 Basel E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1997

2001

Swiss Federal Institute of Technology,

Zurich, CH University of Basel, CH

M.Sc. – Environmental Science Ph.D. – Epidemiology


1997–1998

1998–2001

2001–2003 2003–2009

2009–2016

2016–

Research Assistant, Institute of Atmospheric Science, Swiss Federal Institute of

Technology, Zurich Ph.D. Student, Air Quality Management Agency of Basel/Institute for Social and

Preventive Medicine, Basel Post–Doc, Institute for Social and Preventive Medicine, University of Basel Senior Epidemiologist, Head of the Environmental Health Research Group,

Institute for Social and Preventive Medicine, University of Bern Assistant Professor, Head of the Environmental Exposures and Health Unit,

Swiss Tropical and Public Health Institute, Basel Associate Professor of Environmental Epidemiology, Head of the Environmental

Exposures and Health Unit, Swiss Tropical and Public Health Institute, Basel RESEARCH INTERESTS Environmental epidemiology, including exposure assessment, etiological research and health risk assessments.



TURKEY (elected in 2015 – mandate expires in 2019) Kadir Mutlu HAYRAN, M.D., Ph.D.

TURKEY ADDRESS: Hacettepe University Cancer Institute Department of Preventive Oncology, Ankara, Turkey E–mail: [email protected], [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1988–1994 Hacettepe University Faculty Of Medicine M.D.

1995–1997 Hacettepe University Cancer Institute M.Sc. in Cancer Epidemiology

1997–2002 University of Pittsburgh, Graduate School of Public Health Ph.D. in Epidemiology


1995–1997

1998–2002

2002–2003

2003–2007

2007–2014

2014–date

2013–date

Research Assistant, Preventive Oncology, Institute of Oncology, Hacettepe University

Research Assistant, Graduate School of Public Health, University of Pittsburgh, USA

Research Fellow, Cancer Control and Prevention, University of Pittsburgh (Hillman) Cancer Institute

Assistant Professor, Preventive Oncology Department, Hacettepe University Cancer Institute

Associate Professor, Preventive Oncology Department, Hacettepe University Cancer Institute

Full Professor, Preventive Oncology Department, Hacettepe University Cancer Institute

Chairman, Preventive Oncology Department

RESEARCH INTERESTS Cancer epidemiology; cancer prevention; cancer clinical trials.




UK (elected in 2016 – mandate expires in 2020) Simon TAVARÉ, B.Sc., M.Sc., Ph.D.

UK ADDRESS: CRUK Cambridge Institute University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1974 1975 1979

University of Sheffield, UK University of Sheffield, UK University of Sheffield, UK

B.Sc. Probability & Statistics M.Sc. Probability & Statistics Ph.D. Probability & Statistics


1977–1978 1978–1979 1978–1981 1981–1983 1983–1985 1984–1989 1989–2006

1989–2006 1999–2006 2006–2014



2006–2013

2013–present

Lecturer in Probability and Statistics, University of Sheffield, UK Research Fellow, Medical Biophysics and Computing, University of Utah, USA Instructor of Mathematics, University of Utah, USA Assistant Professor of Statistics, Colorado State University, USA Associate Professor of Statistics, Colorado State University Associate Professor of Mathematics, University of Utah Professor, Department of Mathematics, University of South California (USC),

Los Angeles, USA Professor, Department of Biological Sciences, USC Professor, Department of Preventive Medicine, Keck School of Medicine, USC Research Professor, Department of Biological Sciences, USC Adjunct Research Professor, Department of Biological Sciences, USC Professor, Department of Applied Mathematics and Theoretical Physics,

University of Cambridge Professorial Fellow, Christ's College, Cambridge Professor of Cancer Research (Bioinformatics) Department of Oncology,

University of Cambridge Senior Group Leader, CRUK Cambridge Research Institute Director, Cancer Research UK Cambridge Institute, University of Cambridge

RESEARCH INTERESTS Cancer genomics, evolutionary approaches to cancer, statistical bioinformatics for arrays and sequencing, computational biology, population genetics.



USA (elected in 2014 – mandate expires in 2018) Stephen J. CHANOCK, M.D.

USA ADDRESS: Director, Division of Cancer Epidemiology and Genetics National Cancer Institute, Bethesda, MD 20892 E–mail: [email protected] EDUCATION YEAR INSTITUTION QUALIFICATION

1978 1983

Princeton University, Princeton, NJ, USA Harvard Medical School, Boston, MA, USA

A.B. M.D.


1983–1989

1989–1991 1991–2001

1996–2001

1993–1998

1998–2006

2001–2007

2001–Present

2005–Present

2006–2008

2007–Present

2012–2013

2012–Present

Hospital training – Pediatrics / Infectious diseases / Haematology/Oncology /

Research Haematology, Children’s Hospital, Boston, MA, USA Instructor in Pediatrics, Harvard Medical School, Boston, MA, USA Senior Staff Fellow, Pediatric Oncology Branch, National Cancer Institute,

National Institutes of Health (NCI/NIH), Bethesda, MD Tenure Track Investigator, Pediatric Oncology Branch, NCI/NIH, Bethesda,

MD Assistant Professor of Pediatrics (Adjunct), Uniformed Services, University of

the Health Sciences, Bethesda, MD Assistant Professor of Pediatrics (Adjunct), John Hopkins School of Medicine,

Baltimore, MD Tenured Investigator, Head, Section on Genomic Variation, Pediatric

Oncology Branch, Center for Cancer Research, NCI/NIH, Bethesda, MD Director, Core Genotyping Facility (now Cancer Genomics Research

Laboratory), National Cancer Institute, Gaithersburg, MD and Office of the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

Co–Director, Cancer Genetic Markers of Susceptibility NCI Strategic Initiative, Office of the Director, NCI

Appointed to the Senior Biomedical Research Service, National Institutes of Health, Bethesda, MD

Chief, Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD

Acting Co–director, Center for Cancer Genomics, Office of the Director, National Cancer Institute, Bethesda, MD

Executive Committee, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

RESEARCH INTERESTS Genetics; cancer epidemiology.


adèle green, mbbs, ph.d. · adèle green, mbbs, ph.d. australia . address: qimr berghofer medical...

Documents